The UK IPO’s updated guidance should reduce Section 1(2) objections, but applicants may still face difficult questions about which claim features make a technical contribution...

How can intellectual property rights protect innovations designed specifically for women and underrepresented groups in product safety? This article explores the intersection of inclusive design and IP strategy, examining patents, design rights, and trade marks as tools for safeguarding innovations that address long-overlooked safety gaps in consumer products.

In a decision dated 23rd May 2014, Mr Justice Arnold in the UK High Court dismissed Professor Shanks' appeal and upheld the UKIPO decision not to award Professor Shanks any employee inventor compensation.

There was good news today for the Unitary Patent system. The AG’s opinion stated that Spain’s latest challenges to the UPC are unfounded, that the legal basis for the disputed regulations are valid, affirmed the role of the EPO in the new Unitary Patent system and backed the use of a limited number of languages for the new Unitary Patents.

In a significant recent judgment the Supreme Court (the UK’s highest court) has revisited and overturned a legal principle developed by the UK courts over 100 years.

The High Court of England & Wales has found that Amazon’s use of LUSH as a Google AdWord infringed the registered LUSH trade mark where the sponsored advertisement triggered by the AdWord did not enable consumers to determine easily that the products being offered were not actual LUSH products.

This recent decision of the Intellectual Property Enterprise Court (IPEC) demonstrates the importance of parties being clear in their pleadings about the technical field of the skilled person when seeking to invalidate a patent for obviousness in the UK.

The latest developments in 3D printing and the implications for IP protection.

The High Court of England & Wales has found that House of Fraser’s use of a "Pigeon logo" infringed Jack Wills’ "Mr Wills logo" trade mark on the basis of a likelihood of confusion and also on the basis that the "Pigeon logo" took unfair advantage of the reputation in the "Mr Wills logo".

In the latest development to the patentability of human stem cells, the Advocate General (AG) has recommended that stem cells derived from parthenogenically activated oocytes should not be excluded from patentability any longer.

The Enlarged Board of Appeal at the European Patent Office is poised to resolve a fundamental question that has divided patent practitioners for years: must patent descriptions...

The European Patent Office has released significant updates to its Case Law of the Boards of Appeal, incorporating landmark decisions that reshape how prior art is assessed, claims are interpreted, and appeal procedures are conducted. These changes reflect pivotal rulings from the Technical and Enlarged Boards of Appeal that practitioners should understand for effective EPO proceedings.

The Enlarged Board of Appeal will address fundamental questions about how patent claims should be interpreted using the description and drawings, and what this means for assessing whether amendments introduce added subject-matter. Three competing approaches have emerged in Board of Appeal decisions following G 1/24, each leading to different outcomes when determining if claim amendments extend beyond the original application.

The IPEC has found in favour of a claimant who was groundlessly threatened with patent infringement proceedings.

The Court of Appeal has recently handed down a decision indicating its intention to refer questions relating to the Specific Mechanism to the Court of Justice (Europe's highest court; the CJEU) on an appeal from the Patents County Court.

The UPC Court of Appeal has provided detailed guidance on long-arm jurisdiction and referred critical questions to the CJEU regarding anchor defendants. This analysis examines recent cases including Genevant...

We report on a recent Technical Board of Appeal decision at the EPO which gives us a glimpse at how arguments often used when attempting to establish an inventive step may be perceived by the Boards.

A decision of the Patents Court of the High Court of England and Wales (the ‘Patents Court’) to refuse a stay of proceedings pending the outcome of co-pending proceedings at the European Patent Office (EPO) has been unsuccessfully appealed by HTC in IPCom v HTC.

European patent law offers extra protection for pharmaceuticals that is not available for medical devices.

The Unified Patent Court has now processed hundreds of cases since opening in 2023, revealing emerging patterns in litigation success rates, procedural timelines, and forum preferences.